Dr. Hepgur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 E Sample Rd
Deerfield Beach, FL 33064Phone+1 954-786-6460Fax+1 954-786-7304
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2011 - 2014
- University at BuffaloResidency, Internal Medicine, 2008 - 2011
- Istanbul University FomClass of 1999
Certifications & Licensure
- CA State Medical License 2010 - 2026
- FL State Medical License 2014 - 2026
- TN State Medical License 2014 - 2019
- AL State Medical License 2006 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best Research Presentation Award USC Keck School of Medicine, 2014
- Conquer Cancer Foundation Merit Award American Society of Medical Oncology, 2013
Publications & Presentations
PubMed
- 16 citationsMultiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.Minoo Battiwalla, Mehmet Hepgur, Dalin Pan, Philip L. McCarthy, Manmeet S. Ahluwalia
Cytometry. Part B, Clinical Cytometry. 2010-09-01 - 17 citationsTivozanib in the treatment of renal cell carcinomaMehmet Hepgur, Sarmad Sadeghi, Tanya B. Dorff, David I. Quinn
Biologics. 2013-06-11 - 19 citationsMedical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation.Mehmet Hepgur, Manmeet S. Ahluwalia, N. Anne, Julie Thomas, Hong Liu
Bone Marrow Transplantation. 2011-06-01
Journal Articles
- Evaluation of Skull Thickness and Insertion Torque at the Halo Pin Insertion Areas in the ElderlyEbraheim N, Hepgur M, The Spine Journal
- Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the LungHepgur M Noor M DePlato A, International Journal of Hematology and Oncology
Abstracts/Posters
- Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC)Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan, David I. Quinn;, J Clin Oncol 33, 2015 (suppl 7; abstr 181)
- Identification of biological and inflammatory markers for predicting clinical responses to Sipuleucel-T in mCRPC.Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
- Clinical and biological factors for immune response to Sipuleucel-T for metastatic castrate resistant prostate cancer.Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
- Join now to see all
Press Mentions
- Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast CancerMarch 18th, 2021
Committees
- Peer-reviewer, OncoTargets and Therapy 2014 - Present
- Peer-reviewer, ImmunoTargets and Therapy 2014 - Present
Research History
- Research AssociateRoswell Park Cancer Institute Division of Bone Marrow Transplantation2009 - 2009
Other Languages
- Turkish
External Links
- Google Scholarhttp://scholar.google.com.tw/citations?user=69P0RfgAAAAJ&hl=en
- Pubmedhttp://www.ncbi.nlm.nih.gov/pubmed/?term=hepgur
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: